Congressional Research Service Issues In Focus White Paper on Orphan Drug Act
March 07, 2024
March 07, 2024
WASHINGTON, March 7 -- The Congressional Research Service issued the following In Focus white paper (No. IF12605) on March 5, 2024, by health policy analyst Hassan Z. Sheikh and legislative attorney Hannah-Alise Rogers.
Here are excerpts:
* * *
The Orphan Drug Act: Legal Overview and Policy Considerations
Just under half of all Food and Drug Administration (FDA) drug approvals between 2017 and 2021 were for orphan drugs, which are drugs used to . . .
Here are excerpts:
* * *
The Orphan Drug Act: Legal Overview and Policy Considerations
Just under half of all Food and Drug Administration (FDA) drug approvals between 2017 and 2021 were for orphan drugs, which are drugs used to . . .